Novel antidepressant-like activity of caffeic acid phenethyl ester is mediated by enhanced glucocorticoid receptor function in the hippocampus

Evidence-based Complementary and Alternative Medicine

Volumn 2014, Issue , 2014, Pages

  Lee, Mi Sook ^a,b   Kim, Young Han ^a   Lee, Bo Ram ^a   Kwon, Seung Hae ^a   Moon, Won Jin ^a   Hong, Kwan Su ^a   Song, Yun Seon ^c   Morita, Kyoji ^d   Hahm, Dae Hyun ^b   Shim, Insop ^b   Her, Song ^a  

^a Korea Basic Science Institute (KBSI)   (South Korea)

^b Kyung Hee University   (South Korea)

^c Sookmyung Women's University   (South Korea)

^d SHIKOKU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEIC ACID PHENETHYL ESTER; CORTICOSTERONE; FLUOXETINE; GLUCOCORTICOID RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE P38;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDEPRESSANT ACTIVITY; ARTICLE; CHRONIC STRESS; CHRONIC UNPREDICTABLE STRESS; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CORTICOSTERONE RELEASE; DEPRESSION; ENZYME ACTIVITY; FORCED SWIM TEST; HIPPOCAMPUS; IMMOBILITY; MALE; MOUSE; NONHUMAN; PROTEIN PHOSPHORYLATION; RECEPTOR DOWN REGULATION; TAIL SUSPENSION TEST; TREATMENT DURATION; WESTERN BLOTTING;

EID: 84914694816     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2014/646039     Document Type: Article

References (54)

1. Twardowska K., Rybakowski J., Limbic-hypothalamic-pituitary-adrenal axis in depression (literature review). Psychiatria Polska 1996 30 5 741 755 2-s2.0-0029850948
2. Cubała W. J., Landowski J., Serotoninergic system and limbic-hypothalamic-pituitary-adrenal axis (LHPA axis) in depression. Psychiatria Polska 2006 40 3 415 430 2-s2.0-33747422130
3. Reul J. M. H. M., van den Bosch F. R., de Kloet E. R., Relative occupation of type-I and type-II corticosteroid receptors in rat brain following stress and dexamethasone treatment: functional implications. Journal of Endocrinology 1987 115 3 459 467 10.1677/joe.0.1150459 2-s2.0-0023473436
4. Webster M. J., Knable M. B., O'Grady J., Orthmann J., Weickert C. S., Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders. Molecular Psychiatry 2002 7 9 985 994 10.1038/sj.mp.4001139 2-s2.0-0036428858
5. McGowan P. O., Sasaki A., D'Alessio A. C., Dymov S., Labonté B., Szyf M., Turecki G., Meaney M. J., Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nature Neuroscience 2009 12 3 342 348 10.1038/nn.2270 2-s2.0-60749105468
6. Simic I., Maric N. P., Mitic M., Soldatovic I., Pavlovic Z., Mihaljevic M., Andric S., Radojcic M. B., Adzic M., Phosphorylation of leukocyte glucocorticoid receptor in patients with current episode of major depressive disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2013 40 1 281 285 10.1016/j.pnpbp.2012.10.021 2-s2.0-84869451228
7. Lee M. S., Kim Y. H., Park W. S., Novel antidepressant-like activity of propolis extract mediated by enhanced glucocorticoid receptor function in the hippocampus. Evidence-Based Complementary and Alternative Medicine 2013 2013 10 217853 10.1155/2013/217853
8. Bankova V., Recent trends and important developments in propolis research. Evidence-Based Complementary and Alternative Medicine 2005 2 1 29 32 10.1093/ecam/neh059 2-s2.0-23044479136
9. Murtaza G., Karim S., Akram M. R., Caffeic acid phenethyl ester and therapeutic potentials. BioMed Research International 2014 2014 9 145342 10.1155/2014/145342
10. Tsai S.-K., Lin M.-J., Liao P.-H., Yang C.-Y., Lin S.-M., Liu S.-M., Lin R.-H., Chih C.-L., Huang S.-S., Caffeic acid phenethyl ester ameliorates cerebral infarction in rats subjected to focal cerebral ischemia. Life Sciences 2006 78 23 2758 2762 10.1016/j.lfs.2005.10.017 2-s2.0-33646524060
11. Cengiz N., Colakoglu N., Kavakli A., Sahna E., Parlakpinar H., Acet A., Effects of caffeic acid phenethyl ester on cerebral cortex: Structural changes resulting from middle cerebral artery ischemia reperfusion. Clinical Neuropathology 2007 26 2 80 84 10.5414/NPP26080 2-s2.0-33947143471
12. Altu M. E., Serarslan Y., Bal R., Kontaş T., Ekici F., Melek I. M., Aslan H., Duman T., Caffeic acid phenethyl ester protects rabbit brains against permanent focal ischemia by antioxidant action: a biochemical and planimetric study. Brain Research 2008 1201 135 142 10.1016/j.brainres.2008.01.053 2-s2.0-40849101557
13. Wei X., Ma Z., Fontanilla C. V., Zhao L., Xu Z. C., Taggliabraci V., Johnstone B. H., Dodel R. C., Farlow M. R., Du Y., Caffeic acid phenethyl ester prevents cerebellar granule neurons (CGNs) against glutamate-induced neurotoxicity. Neuroscience 2008 155 4 1098 1105 10.1016/j.neuroscience.2008.06.056 2-s2.0-50249116159
14. Jin U. H., Chung T. W., Song K. H., Ganglioside GM3 is required for caffeic acid phenethyl ester-induced megakaryocytic differentiation of human chronic myelogenous leukemia K562 cells. Biochemistry and Cell Biology 2014 92 4 243 249
15. Rossi C., Angelucci A., Costantin L., Braschi C., Mazzantini M., Babbini F., Fabbri M. E., Tessarollo L., Maffei L., Berardi N., Caleo M., Brain-derived neurotrophic factor (BDNF) is required for the enhancement of hippocampal neurogenesis following environmental enrichment. European Journal of Neuroscience 2006 24 7 1850 1856 10.1111/j.1460-9568.2006.05059.x 2-s2.0-33750054969
16. Galliher-Beckley A. J., Cidlowski J. A., Emerging roles of glucocorticoid receptor phosphorylation in modulating glucocorticoid hormone action in health and disease. IUBMB Life 2009 61 10 979 986 10.1002/iub.245 2-s2.0-73349090272
17. Miller A. L., Webb M. S., Copik A. J., Wang Y., Johnson B. H., Kumar R., Thompson E. B., p38 mitogen-activated protein kinase (MAPK) is a key mediator in glucocorticoid-induced apoptosis of lymphoid cells: correlation between p38 MAPK activation and site-specific phosphorylation of the human glucocorticoid receptor at serine 211. Molecular Endocrinology 2005 19 6 1569 1583 2-s2.0-22344458207 10.1210/me.2004-0528
18. Ducottet C., Aubert A., Belzung C., Susceptibility to subchronic unpredictable stress is related to individual reactivity to threat stimuli in mice. Behavioural Brain Research 2004 155 2 291 299 10.1016/j.bbr.2004.04.020 2-s2.0-4444370035
19. Toratani A., Soga H., Fukumitsu H., Soumiya H., Furukawa Y., Furukawa S., Caffeic acid phenethyl ester ameliorates depression- and anxiety-like behaviors of mice exposed to chronic mild stress. Journal of Neurophysiology and Neurological Disorders 2014 1 1 1 8
20. Bezerra R. M., Veiga L. F., Caetano A. C., Rosalen P. L., Amaral M. E. C., Palanch A. C., de Alencar S. M., Caffeic acid phenethyl ester reduces the activation of the nuclear factor b pathway by high-fat diet-induced obesity in mice. Metabolism 2012 61 11 1606 1614 10.1016/j.metabol.2012.04.006 2-s2.0-84867888478
21. Kurauchi Y., Hisatsune A., Isohama Y., Mishima S., Katsuki H., Caffeic acid phenethyl ester protects nigral dopaminergic neurons via dual mechanisms involving haem oxygenase-1 and brain-derived neurotrophic factor. The British Journal of Pharmacology 2012 166 3 1151 1168 10.1111/j.1476-5381.2012.01833.x 2-s2.0-84860868425
22. Kerman M., Kanter M., Coşkun K. K., Erboga M., Gurel A., Neuroprotective effects of Caffeic acid phenethyl ester on experimental traumatic brain injury in rats. Journal of Molecular Histology 2012 43 1 49 57 10.1007/s10735-011-9376-9 2-s2.0-84856540774
23. Petit-Demouliere B., Chenu F., Bourin M., Forced swimming test in mice: a review of antidepressant activity. Psychopharmacology 2005 177 3 245 255 10.1007/s00213-004-2048-7 2-s2.0-12344283814
24. Steru L., Chermat R., Thierry B., Simon P., The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 1985 85 3 367 370 10.1007/BF00428203 2-s2.0-0021990491
25. Lee M.-S., Park W.-S., Kim Y. H., Kwon S.-H., Jang Y.-J., Han D., Morita K., Her S., Antidepressant-like effects of Cortex Mori Radicis extract via bidirectional phosphorylation of glucocorticoid receptors in the hippocampus. Behavioural Brain Research 2013 236 1 56 61 10.1016/j.bbr.2012.08.028 2-s2.0-84865959936
26. Lee M. S., Kwon E. H., Choi H. S., Kwon S. H., Lee C. H., Shim I. S., Lee S. K., Her S., Quantification of cellular uptake and in vivo tracking of transduction using real-time monitoring. Biochemical and Biophysical Research Communications 2010 394 2 348 353 10.1016/j.bbrc.2010.03.009 2-s2.0-77950189694
27. Adzic M., Djordjevic J., Djordjevic A., Niciforovic A., Demonacos C., Radojcic M., Krstic-Demonacos M., Acute or chronic stress induce cell compartment-specific phosphorylation of glucocorticoid receptor and alter its transcriptional activity in Wistar rat brain. Journal of Endocrinology 2009 202 1 87 97 10.1677/JOE-08-0509 2-s2.0-67650753710
28. Cryan J. F., Mombereau C., Vassout A., The tail suspension test as a model for assessing antidepressant activity: Review of pharmacological and genetic studies in mice. Neuroscience and Biobehavioral Reviews 2005 29 4-5 571 625 10.1016/j.neubiorev.2005.03.009 2-s2.0-19944380200
29. Bai F., Li X., Clay M., Lindstrom T., Skolnick P., Intra- and interstrain differences in models of 'behavioral despair'. Pharmacology Biochemistry and Behavior 2001 70 2-3 187 192 10.1016/S0091-3057(01)00599-8 2-s2.0-0035171425
30. Lucki I., Dalvi A., Mayorga A. J., Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice. Psychopharmacology 2001 155 3 315 322 10.1007/s002130100694 2-s2.0-0035017384
31. Szymańska M., Budziszewska B., Jaworska-Feil L., Basta-Kaim A., Kubera M., Les̈kiewicz M., Regulska M., Lasoń W., The effect of antidepressant drugs on the HPA axis activity, glucocorticoid receptor level and FKBP51 concentration in prenatally stressed rats. Psychoneuroendocrinology 2009 34 6 822 832 10.1016/j.psyneuen.2008.12.012 2-s2.0-67349110410
32. Strausbaugh H. J., Dallman M. F., Levine J. D., Repeated, but not acute, stress suppresses inflammatory plasma extravasation. Proceedings of the National Academy of Sciences of the United States of America 1999 96 25 14629 14634 10.1073/pnas.96.25.14629 2-s2.0-0033431042
33. Silberman D. M., Wald M. R., Genaro A. M., Acute and chronic stress exert opposing effects on antibody responses associated with changes in stress hormone regulation of T-lymphocyte reactivity. Journal of Neuroimmunology 2003 144 1-2 53 60 10.1016/j.jneuroim.2003.08.031 2-s2.0-0142164970
34. Sapolsky R. M., Krey L. C., McEwen B. S., Glucocorticoid-sensitive hippocampal neurons are involved in terminating the adrenocortical stress response. Proceedings of the National Academy of Sciences of the United States of America 1984 81 19 I 6174 6177 10.1073/pnas.81.19.6174 2-s2.0-0342717758
35. Holsboer F., Stress, hypercortisolism and corticosteroid receptors in depression: implicatons for therapy. Journal of Affective Disorders 2001 62 1-2 77 91 10.1016/S0165-0327(00)00352-9 2-s2.0-0035153486
36. Anacker C., Zunszain P. A., Carvalho L. A., Pariante C. M., The glucocorticoid receptor: pivot of depression and of antidepressant treatment? Psychoneuroendocrinology 2011 36 3 415 425 10.1016/j.psyneuen.2010.03.007 2-s2.0-79951956849
37. Eickelberg O., Roth M., Lörx R., Bruce V., Rüdiger J., Johnson M., Block L. H., Ligand-independent activation of the glucocorticoid receptor by β 2- adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells. Journal of Biological Chemistry 1999 274 2 1005 1010 10.1074/jbc.274.2.1005 2-s2.0-0033534727
38. Pariante C. M., Miller A. H., Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment. Biological Psychiatry 2001 49 5 391 404 10.1016/S0006-3223(00)01088-X 2-s2.0-0035280252
39. Schmidt H. D., Banasr M., Duman R. S., Future antidepressant targets: neurotrophic factors and related signaling cascades. Drug Discovery Today: Therapeutic Strategies 2008 5 3 151 156 2-s2.0-61849083112 10.1016/j.ddstr.2008.10.003
40. Mercier G., Lennon A. M., Renouf B., MAP kinase activation by fluoxetine and its relation to gene expression in cultured rat astrocytes. Journal of Molecular Neuroscience 2004 24 2 207 216
41. Kim S. W., Ha N. Y., Kim K. I., Park J. K., Lee Y. H., Memory-improving effect of formulation-MSS by activation of hippocampal MAPK/ERK signaling pathway in rats. Journal of Biochemistry and Molecular Biology 2008 41 3 242 247 2-s2.0-42049108234
42. Shi H.-S., Zhu W.-L., Liu J.-F., Luo Y.-X., Si J.-J., Wang S.-J., Xue Y.-X., Ding Z.-B., Shi J., Lu L., PI3K/Akt signaling pathway in the basolateral amygdala mediates the rapid antidepressant-like effects of trefoil factor 3. Neuropsychopharmacology 2012 37 12 2671 2683 10.1038/npp.2012.131 2-s2.0-84867581733
43. Sun C.-Y., Qi S.-S., Lou X.-F., Sun S.-H., Wang X., Dai K.-Y., Hu S.-W., Liu N.-B., Changes of learning, memory and levels of CaMKII, CaM mRNA, CREB mRNA in the hippocampus of chronic multiple-stressed rats. Chinese Medical Journal 2006 119 2 140 147 2-s2.0-33644976504
44. Shi Y., Yuan Y., Xu Z., Pu M., Wang C., Zhang Y., Liu Z., Li L., Zhang Z., Genetic variation in the calcium/calmodulin-dependent protein kinase (CaMK) pathway is associated with antidepressant response in females. Journal of Affective Disorders 2012 136 3 558 566 10.1016/j.jad.2011.10.030 2-s2.0-84857371055
45. Nibuya M., Nestler E. J., Duman R. S., Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. Journal of Neuroscience 1996 16 7 2365 2372 2-s2.0-0029992189
46. Gundersen B. B., Briand L. A., Onksen J. L., Lelay J., Kaestner K. H., Blendy J. A., Increased hippocampal neurogenesis and accelerated response to antidepressants in mice with specific deletion of CREB in the hippocampus: role of cAMP response-element modulator τ Journal of Neuroscience 2013 33 34 13673 13685 10.1523/JNEUROSCI.1669-13.2013 2-s2.0-84882731883
47. Chartoff E. H., Papadopoulou M., MacDonald M. L., Parsegian A., Potter D., Konradi C., Carlezon W. A., Desipramine reduces stress-activated dynorphin expression and CREB phosphorylation in NAc tissue. Molecular Pharmacology 2009 75 3 704 712 10.1124/mol.108.051417 2-s2.0-62149094381
48. Dwivedi Y., Rizavi H. S., Roberts R. C., Conley R. C., Tamminga C. A., Pandey G. N., Reduced activation and expression of ERK1/2 MAP kinase in the post-mortem brain of depressed suicide subjects. Journal of Neurochemistry 2001 77 3 916 928 10.1046/j.1471-4159.2001.00300.x 2-s2.0-0035020808
49. Fumagalli F., Molteni R., Calabrese F., Frasca A., Racagni G., Riva M. A., Chronic fluoxetine administration inhibits extracellular signal-regulated kinase 1/2 phosphorylation in rat brain. Journal of Neurochemistry 2005 93 6 1551 1560 10.1111/j.1471-4159.2005.03149.x 2-s2.0-20744432159
50. Krstic M. D., Rogatsky I., Yamamoto K. R., Garabedian M. J., Mitogen-activated and cyclin-dependent protein kinases selectively and differentially modulate transcriptional enhancement by the glucocorticoid receptor. Molecular and Cellular Biology 1997 17 7 3947 3954 2-s2.0-0030998260
51. Rogatsky I., Logan S. K., Garabedian M. J., Antagonism of glucocorticoid receptor transcriptional activation by the c-Jun N-terminal kinase. Proceedings of the National Academy of Sciences of the United States of America 1998 95 5 2050 2055 10.1073/pnas.95.5.2050 2-s2.0-0032478254
52. Ismaili N., Garabedian M. J., Modulation of glucocorticoid receptor function via phosphorylation. Annals of the New York Academy of Sciences 2004 1024 86 101 10.1196/annals.1321.007 2-s2.0-3042788350
53. Cui H., Sakamoto H., Higashi S., Kawata M., Effects of single-prolonged stress on neurons and their afferent inputs in the amygdala. Neuroscience 2008 152 3 703 712 10.1016/j.neuroscience.2007.12.028 2-s2.0-40949158011
54. Vinet J., Carra S., Blom J. M., Brunello N., Barden N., Tascedda F., Chronic treatment with desipramine and fluoxetine modulate BDNF, CaMKK α and CaMKK β mRNA levels in the hippocampus of transgenic mice expressing antisense RNA against the glucocorticoid receptor. Neuropharmacology 2004 47 7 1062 1069 10.1016/j.neuropharm.2004.07.035 2-s2.0-8844259560